Details for New Drug Application (NDA): 210859
✉ Email this page to a colleague
The generic ingredient in EZETIMIBE is ezetimibe; simvastatin. There are twenty-four drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the ezetimibe; simvastatin profile page.
Summary for 210859
Tradename: | EZETIMIBE |
Applicant: | Hetero Labs Ltd Iii |
Ingredient: | ezetimibe |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 210859
Physiological Effect | Decreased Cholesterol Absorption |
Medical Subject Heading (MeSH) Categories for 210859
Suppliers and Packaging for NDA: 210859
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
EZETIMIBE | ezetimibe | TABLET;ORAL | 210859 | ANDA | Camber Pharmaceuticals, Inc. | 31722-628 | 31722-628-01 | 100 TABLET in 1 BOTTLE (31722-628-01) |
EZETIMIBE | ezetimibe | TABLET;ORAL | 210859 | ANDA | Camber Pharmaceuticals, Inc. | 31722-628 | 31722-628-30 | 30 TABLET in 1 BOTTLE (31722-628-30) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
Approval Date: | Jul 26, 2022 | TE: | AB | RLD: | No |
Complete Access Available with Subscription